Physician profile
Rishina De Leon
NPI 1730745407
$1,916.90
in general payments reported to CMS, 2019-2025
23 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $748 · 2022: $626 · 2023: $208 · 2024: $200 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $348.96 | 2021-2022 | |
| Amgen INC. | $337.82 | 2021-2024 | Repatha |
| Amarin Pharma, INC. | $324.42 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $133.27 | 2022-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $91.33 | 2023-2024 | |
| Pfizer INC. | $75.38 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $69.67 | 2021-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.65 | 2022 | |
| Esperion Therapeutics, INC. | $59.48 | 2021-2023 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.66 | 2022-2023 | Lifevest |
| Arbor Pharmaceuticals, INC. | $49.51 | 2021-2022 | |
| Boston Scientific Corporation | $42.56 | 2023-2025 | Watchman Flx, Watchman Access System |
| Lexicon Pharmaceuticals, INC. | $41.49 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $40.86 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $32.25 | 2021-2023 | Evkeeza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $31.87 | 2025 | Attruby |
| Althera Pharmaceuticals LLC | $27.75 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $25.51 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.09 | 2023 | Arcalyst |
| Abiomed | $16.16 | 2024 | Impella |
| Edwards Lifesciences Corporation | $14.90 | 2025 | Sapien 3 Ultra Resilia |
| G Medical Diagnostic Services, INC. | $12.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishina De Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.